期刊文献+

卵巢浆液性囊腺癌中PD-L1的表达和血清CA125对评价恶性程度的意义 被引量:1

Significance of PD-L1 expression in ovarian serous cystadenocarcinoma combined with serum CA125 in evaluating ovarian carcinoma malignancy behavior
下载PDF
导出
摘要 目的:研究PD-L1在卵巢浆液性囊腺癌中的表达,结合患者术前CA125值,探讨二者对评价肿瘤生物学恶性程度的意义。方法:应用免疫组织化学法检测36例卵巢浆液性囊腺癌和20例正常卵巢组织蜡块中PD-L1的表达情况,收集36例卵巢癌患者术前血清CA125值,分析卵巢癌组织PD-L1表达与卵巢癌临床病理特征的关系及术前血清CA125的相关性。结果:卵巢浆液性囊腺癌组织中PD-L1的阳性表达率为88.9%(32/36),显著高于其在正常卵巢组织中的表达40.0%(8/20),差异有统计学意义(P<0.01)。分化程度G2-3级组中PD-L1的阳性率显著高于G1级组,PD-L1与FIGO分期无明显相关性,与患者术前CA125值呈正相关(r=0.739,P<0.01)。结论:PD-L1的表达与术前血清CA125的增高程度结合分析对判断卵巢浆液性囊腺癌的生物学恶性程度有重要意义。 Objective:To evaluate the malignancy behavior of ovarian serous cystadenocarcinoma with PD -L1 ex-pression and serum CA125.Methods:All 36 cases of ovarian serous cystadenocarcinoma and 20 cases of normal ovary tissues were collected,and the level of pre -operational serum CA125 in ovarian carcinoma patients was collected. PD -L1 was detected with immunohistochemistry in all cases.Results:The positive expression rates of PD -L1 was 88.9%(32 /36)in ovarian serous cystadenocarcinoma tissues,obviously higher than 40.0%(8 /20)in normal o-vary tissues with significant difference (P 〈0.01).The positive rate of PD -L1 was obviously higher in G2 -3 group than that in G1 group.The expression of PD -L1 was positively correlated with the pre -operational serum CA125 lev-el(r =0.739,P 〈0.01).Conclusion:The expression of PD -L1 and high level of pre -operational serum CA125 can evaluate ovarian carcinoma malignancy behavior.
出处 《现代肿瘤医学》 CAS 2015年第18期2658-2660,共3页 Journal of Modern Oncology
基金 包头市医药卫生科技发展基金(编号:Wsjj2014031)
关键词 卵巢肿瘤 PD-L1 血清CA125 免疫组织化学 ovarian neoplasms immunohistochemistry
  • 相关文献

参考文献15

  • 1郝志强,李晓凤.Bcl-2基因表达与上皮性卵巢癌的研究进展[J].癌症进展,2013,11(4):341-344. 被引量:3
  • 2于晓伟,李春红,张松灵,张晓霞,何津,张丽宏,崔满华.卵巢癌患者PD-L1的表达研究[J].中国实验诊断学,2010,14(11):1854-1856. 被引量:3
  • 3主改侠,刘莹,张飞跃.卵巢浆液性上皮癌中HLA-DR的表达结合血清CA125对评价肿瘤生物学恶性程度的意义[J].第四军医大学学报,2009,30(7):640-642. 被引量:6
  • 4Dong H, Strome SE, Salomao DR, et al. Tumor - associated B7 - HI promotes T - cell apoptosis : a potential mechanism of immune evasion[ J]. Nat Med ,2002,8 ( 8 ) :793 - 800.
  • 5Thompson RH, Dong H, Kwon ED. Implications of B7 -H1 expres- sion in clear cell of the kidney for prognostication and therapy[ J]. Clin Cancer Res ,2007,13 ( 2 Suppl) :709 - 715.
  • 6Ghebeh I-I, Mohammed S, AL - Omair A, et al. The B7 - H1 ( PD - L1 ) T Lymphocyte - inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high - risk prognostic factors [ J ]. Neoplasia, 2006, 8 (3) :190-198.
  • 7Bigelow E, Bever KM, Xu H, et al. Immunohistochemical staining of B7 - H1 ( PD - L1 ) on paraffin - embedded slides of pancreatic adenocarcinoma tissue [ J ]. J Vis Exp ,2013 ,71 (3) :4059.
  • 8Hua D,Sun J,Mao Y,et al. B7 -H1 expression is associated with expansion of regulatory T ceils in colorectal carcinoma[ J]. World J Gastroentero1,2012,18 (9) :971 - 978.
  • 9Hamanishi J, Mandai M, Iwasaki M, et al. Programmed cell death ligand 1 and tumor - infiltrating CD8 + T lymphocytes are prognos- tic factors of human ovarian cancer[J]. Proc Natl Acad Sci USA, 2007,104(9) :3360-3365.
  • 10Azuma T,Yao S,Zhu G,et al. B7 -H1 is a ubiquitous antiapop- totic receptor on cancer cells [ J ]. Blood, 2008,111 ( 7 ) : 3635 - 3643.

二级参考文献48

  • 1韩克强,吴娅利.抗凋亡基因Bcl-2与肿瘤的研究进展[J].中国医师杂志,2003,5(S1):303-305. 被引量:2
  • 2李巍,崔恒,冯捷,李艺.卵巢癌诊断的研究进展[J].中华妇产科杂志,2005,40(7):496-498. 被引量:74
  • 3李金凤,张震宇,王淑珍,刘晋玮.卵巢癌细胞和脐血树突状细胞融合瘤苗抗肿瘤免疫效应的初步研究[J].中国肿瘤临床,2007,34(14):789-793. 被引量:8
  • 4Lovig T, Andersen SN, Thorstensen L, et al. Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis [ J ]. Br J Cancer, 2002,87 ( 7 ) : 756 -762.
  • 5Ishigami S, Aikou T, Natsugoe S, et al. Prognostic value of HLADR expression and dendritic cell infiltration in gastric cancer [ J ]. Oncology, 2005,55( 1 ) :65 -69.
  • 6Geiser JP, Miller GA, Lee TH, et al. Relationship of preoperative serum CA125 to survival in epithelial ovarian carcinoma[ J]. J Reprod Med, 2002,41 ( 1 ) : 164 - 167.
  • 7Markowska J, Wilkoszarska J, Ernerich J, et al. Factors influencing period of time between negative second-look laparotom and ovarian carcinoma recurrence. Multicenter study in Poland [ J ]. Eur J Gynaccol Oncol, 2004,21 ( 1 ) : 164 - 167
  • 8万俊辉,蔡丽萍.Survivin蛋白和Bcl-2蛋白在上皮性卵巢癌中的表达及相关性[J].实用临床医学(江西),2007,8(6):4-6. 被引量:4
  • 9Groh V,Wu J,Yee C,et al.Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation[J].Nature,2002,419(6908):734.
  • 10Pardoll DM.Spinning molecular immunology into successful immunotherapy[J].Nat Rev Immunol.2002(4):227.

共引文献9

同被引文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部